| For: | Feeney L, Harley IJ, McCluggage WG, Mullan PB, Beirne JP. Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes. World J Clin Oncol 2020; 11(11): 868-889 [PMID: 33312883 DOI: 10.5306/wjco.v11.i11.868] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i11/868.htm |
| Number | Citing Articles |
| 1 |
Abubakr Mohamed Ali Nasr. Breast and Gynecological Cancers - New Perspectives and Applications in Their Treatment. Oncology 2025; 3 doi: 10.5772/intechopen.1007912
|
| 2 |
Sara Yaser Barham, Dorcas Omotade, Seda Yılmaz, Fatma Tuba Akdeniz, Betül Çapar Goralı, Rukset Attar, Turgay İsbir. Investigation of Polymorphisms in Global Genome Repair Genes in Patients With Ovarian Cancer in the Turkish Population. Cancer Control 2024; 31 doi: 10.1177/10732748241270597
|
| 3 |
Faezeh Ghorbanizamani, Hichem Moulahoum, Figen Zihnioglu, Suna Timur. Molecularly imprinted polymers-based biosensors for gynecological diagnostics and monitoring. Talanta Open 2024; 10 doi: 10.1016/j.talo.2024.100364
|
| 4 |
Senuri De Silva, Asfa Alli-Shaik, Jayantha Gunaratne. Machine Learning-Enhanced Extraction of Biomarkers for High-Grade Serous Ovarian Cancer from Proteomics Data. Scientific Data 2024; 11(1) doi: 10.1038/s41597-024-03536-1
|
| 5 |
Diana Žilovič, Ieva Vaicekauskaitė, Rūta Čiurlienė, Rasa Sabaliauskaitė, Sonata Jarmalaitė. Uterine Cavity Lavage Mutation Analysis in Lithuanian Ovarian Cancer Patients. Cancers 2023; 15(3) doi: 10.3390/cancers15030868
|
| 6 |
Dimitra Stergiopoulou, Athina Markou, Lydia Giannopoulou, Paul Buderath, Ioanna Balgkouranidou, Nikolaos Xenidis, Stylianos Kakolyris, Sabine Kasimir-Bauer, Evi Lianidou. Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients. Cancers 2022; 14(15) doi: 10.3390/cancers14153790
|
| 7 |
Kawaljit Kaur. Natural Killer (NK) Cell-Based Therapies Have the Potential to Treat Ovarian Cancer Effectively by Targeting Diverse Tumor Populations and Reducing the Risk of Recurrence. Cancers 2025; 17(23) doi: 10.3390/cancers17233862
|
| 8 |
Yuvaraj Sekar, Deeptha Ishwar, Bo Tan, Krishnan Venkatakrishnan. Nano biosensor unlocks tumor derived immune signals for the early detection of ovarian cancer. Biosensors and Bioelectronics 2025; 278 doi: 10.1016/j.bios.2025.117368
|
| 9 |
Naoki Kawahara, Shoichiro Yamanaka, Sumire Sugimoto, Junya Kamibayashi, Kyohei Nishikawa, Ryuji Kawaguchi, Fuminori Kimura. The Prognosis Predictive Score around Neo Adjuvant Chemotherapy (PPSN) Improves Diagnostic Efficacy in Predicting the Prognosis of Epithelial Ovarian Cancer Patients. Cancers 2023; 15(20) doi: 10.3390/cancers15205062
|
| 10 |
Arpan Dey Bhowmik, Pallab Shaw, Mohan Shankar Gopinatha Pillai, Geeta Rao, Shailendra Kumar Dhar Dwivedi. Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer. Cancer Letters 2025; 611 doi: 10.1016/j.canlet.2024.217357
|
| 11 |
Trudy J. Philips, Britt K. Erickson, Stefani N. Thomas. Opportunities for predictive proteogenomic biomarkers of drug treatment sensitivity in epithelial ovarian cancer. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1503107
|
| 12 |
Naoki Kawahara, Hiroshi Kobayashi, Tomoka Maehana, Kana Iwai, Yuki Yamada, Ryuji Kawaguchi, Junko Takahama, Nagaaki Marugami, Hirotaka Nishi, Yosuke Sakai, Hirokuni Takano, Toshiyuki Seki, Kota Yokosu, Yukihiro Hirata, Koyo Yoshida, Takafumi Ujihira, Fuminori Kimura. MR Relaxometry for Discriminating Malignant Ovarian Cystic Tumors: A Prospective Multicenter Cohort Study. Diagnostics 2024; 14(11) doi: 10.3390/diagnostics14111069
|
| 13 |
Michaela A. Boti, Marios A. Diamantopoulos, Sevastiana Charalampidou, Andreas Scorilas. LncRNAs in Ovarian Cancer: Emerging Insights and Future Perspectives in Tumor Biology and Clinical Applications. Cancers 2026; 18(3) doi: 10.3390/cancers18030484
|
| 14 |
Shruti Jain, Nimrah Nadeem, Benjamin Ulfenborg, Maria Mäkelä, Shamima Afrin Ruma, Joonas Terävä, Kaisa Huhtinen, Janne Leivo, Björg Kristjansdottir, Kim Pettersson, Karin Sundfeldt, Kamlesh Gidwani. Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer. International Journal of Cancer 2022; 151(7) doi: 10.1002/ijc.34111
|
| 15 |
Agnieszka Drab, Krystian Wdowiak, Wiesław Kanadys, Maria Malm, Joanna Dolar-Szczasny, Urszula Religioni. Hypertension and Ovarian Cancer Risk: a Meta-Analysis of Observational Studies
with 2,497,898 participants. Archives of Medical Science 2025; doi: 10.5114/aoms/210330
|
| 16 |
David Viveros-Carreño, Isabel Beshar, Nuria Agustí, Ananya Murthy, Nathalia Mora-Soto, Maria D. Iniesta, Karla Barajas, Alexander Melamed, J Alejandro Rauh-Hain, Roni Nitecki Wilke. Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants. International Journal of Gynecological Cancer 2026; 36(6) doi: 10.1016/j.ijgc.2026.104676
|
| 17 |
Louise Faaborg, Rikke Fredslund Andersen, Sara WC Wen, Caroline B Thomsen, Louise Raunkilde, Torben Frøstrup Hansen, Lars Henrik Jensen, Karina Dahl Steffensen, Anders Jakobsen. Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer. Future Oncology 2023; 19(35) doi: 10.2217/fon-2023-0111
|
| 18 |
Xiaoxue Zhang, Liping Han, Fangfang Nie, Huimin Zhang, Liming Li, Ruopeng Liang. Development of a radiomic model to predict CEACAM1 expression and prognosis in ovarian cancer. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-99625-1
|
| 19 |
I Made Darmayasa, Ni Luh Putu Padmawati. Quality of Life of Patients with Advanced Stage Ovarian Cancer from Sanglah Hospital Denpasar: Serial Case Report. European Journal of Medical and Health Sciences 2022; 4(3) doi: 10.24018/ejmed.2022.4.3.1300
|
| 20 |
Sharon O’Toole, James Beirne, John O’Leary. Rare and Uncommon Gynaecological Cancers. 2026; doi: 10.1007/978-3-032-14420-1_25
|
| 21 |
Khaled Alrosan, Ali Alsuraifi, Clare Hoskins, Alan Richardson. Encapsulation of navitoclax in non-folate and in folate targeted comb-shaped polymer nanoparticles. Next Research 2026; 13 doi: 10.1016/j.nexres.2026.102365
|
| 22 |
Mukurdipi Ray, Bittu Bhukkal. Evaluating the Impact of Retroperitoneal Lymphadenectomy in Terms of Morbidity and Survival in Advanced Epithelial Ovarian Cancer. Cureus 2025; doi: 10.7759/cureus.92819
|
| 23 |
Irina Larionova, Pavel Iamshchikov, Anna Kazakova, Militsa Rakina, Maxim Menyalo, Kadriia Enikeeva, Guzel Rafikova, Yuliya Sharifyanova, Valentin Pavlov, Alisa Villert, Larisa Kolomiets, Julia Kzhyshkowska. Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1414716
|
| 24 |
Yağmur Soykan, Atiye Seda Yar Sağlam. OVER KANSERİ, SİRKADİYEN RİTİM VE KRONOKEMOTERAPİ. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 2025; 22(1) doi: 10.38136/jgon.1655014
|
| 25 |
Hypertension as a Predictor of Ovarian Cancer Risk: A Systematic Review and Meta‐Analysis. Health Science Reports 2026; 9(3) doi: 10.1002/hsr2.72057
|
| 26 |
Somayeh Hashemi Sheikhshabani, Zeinab Amini‐Farsani, Nesa Kazemifard, Parastoo Modarres, Zahra Amini‐Farsani, Mir Davood Omrani, Soudeh Ghafouri‐Fard. Meta‐analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer. Cancer Reports 2023; 6(12) doi: 10.1002/cnr2.1884
|
| 27 |
Qingqing Tan, Yan Zhao, Zhaoyang Wu, Weiheng Kong, Lujuan Xu, Fengli Qu. Advances in nanotechnology-based platforms for liquid biopsy: Unlocking precision molecular classification in ovarian cancer. TrAC Trends in Analytical Chemistry 2026; 195 doi: 10.1016/j.trac.2025.118558
|
| 28 |
Angelique Loor, Kyeara N. Mack, David Bauer, Aidan Ingham, Edwin C. Pratt, Jason S. Lewis. Minimal chemical modification enables alpha/beta radiolabeling of sacituzumab govitecan for targeted therapy in high grade serous ovarian cancer. European Journal of Nuclear Medicine and Molecular Imaging 2026; 53(7) doi: 10.1007/s00259-026-07820-7
|
| 29 |
Rusul Hammoodi Hasan Kabla , Jinan M. Abed-al-Zahra. The Crocus Sativus Stigma Extract as Anticancer for SKOV-3 Cell Line. Al-Kufa University Journal for Biology 2024; 16(2) doi: 10.36320/ajb/v16.i2.16687
|
| 30 |
Nashrah Mustafa, Mehrin Haque Tanisha, Fariha Tasneem, Md Ayman Siddique, Zubaier Ahmed, Namara Mariam Chowdhury, Fazle Rabbi. Translating Liquid Biopsy into Practice- The Promise and Challenges of Circulating Tumor Cells in Ovarian and Lung Cancer Management. Biomarker Insights 2026; 21 doi: 10.1177/11772719261438618
|
| 31 |
Alaa Ibrahim Mohamed Amer, Sara A. Darwish, Nehal Heabah. Prognostic significance of hypoxia-induced autophagy related markers in malignant surface epithelial ovarian tumours. Polish Journal of Pathology 2026; 77(1) doi: 10.5114/pjp.2026.161233
|
| 32 |
Shikha Rani, Dominic Guanzon, Andrew Lai, Katherin Scholz‐Romero, Lewis Perrin, Rohan Lourie, Vaibhavi Joshi, Amy E. McCart Reed, Kaltin Ferguson, Aase Handberg, Andreas Möller, Carlos Salomon. Small Extracellular Vesicle and Total Lipid Profiles Provide a Diagnostic Advantage Over CA‐125 Across Ovarian Cancer Subtypes. Journal of Extracellular Vesicles 2026; 15(9) doi: 10.1002/jev2.70348
|
| 33 |
Naoki Kawahara, Ryuji Kawaguchi, Keita Waki, Tomoka Maehana, Shoichiro Yamanaka, Yuki Yamada, Fuminori Kimura. The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-27333-1
|
| 34 |
Christine Pampeno, Silvana Opp, Alicia Hurtado, Daniel Meruelo. Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment. International Journal of Molecular Sciences 2024; 25(5) doi: 10.3390/ijms25052925
|
| 35 |
Faye Lewis, James Beirne, Brian Henderson, Lucy Norris, Karen Cadoo, Tanya Kelly, Cara Martin, Sinéad Hurley, Marika Kanjuga, Lorraine O'Driscoll, Kathy Gately, Ezgi Oner, Volga M. Saini, Doug Brooks, Stavros Selemidis, Waseem Kamran, Niamh Haughey, Patrick Maguire, Catherine O'Gorman, Feras Abu Saadeh, Mark P. Ward, John J. O'Leary, Sharon A. O'Toole. Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma. Cancer Letters 2024; 605 doi: 10.1016/j.canlet.2024.217279
|
| 36 |
Lukasz Kuryk, Sara Mathlouthi, Lisa Casagrande, Cristiano Pesce, Francesco Tognetti, Alessio Malfanti, Aleksander Masny, Paolo Caliceti, Mariangela Garofalo. Dynamic 3D microfluidic platform for exploring combined targeted therapy, chemotherapy, and virotherapy delivery in ovarian cancer. Drug Delivery and Translational Research 2026; 16(8) doi: 10.1007/s13346-025-01997-4
|
| 37 |
Faye Lewis, Mark P. Ward, Feras Abu Saadeh, Catherine O'Gorman, Patrick J. Maguire, James P. Beirne, Waseem Kamran, Elzahra Ibrahim, Lucy Norris, Tanya Kelly, Sinéad Hurley, Brian Henderson, Marika Kanjuga, Lorraine O'Driscoll, Kathy Gately, Ezgi Oner, Volga M. Saini, Karen Cadoo, Cara Martin, John J. O'Leary, Sharon A. O'Toole. A pilot study evaluating the feasibility of enriching and detecting circulating tumour cells from peripheral and ovarian veins in rare epithelial ovarian carcinomas. European Journal of Surgical Oncology 2025; 51(4) doi: 10.1016/j.ejso.2025.109721
|
| 38 |
Abigél Balla, Jong Bhak, Orsolya Biró. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer. Molecular and Cellular Probes 2022; 66 doi: 10.1016/j.mcp.2022.101871
|
| 39 |
Joanna Kirmuć, Marcin Jóźwik, Karol Kramkowski. Platelet activation and eicosanoid signaling in ovarian cancer: implications for biomarker development. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-12848-x
|
| 40 |
Revathi Unni K, Amrisa Pavithra Elango, Roobanayaki Subramanian, Santhy KS. The Evolving Landscape of Ovarian Cancer: Innovations in Biotechnology and Artificial Intelligence- Based Screening and Treatment. Current Treatment Options in Oncology 2025; 26(7) doi: 10.1007/s11864-025-01331-7
|
| 41 |
Sadie Klein, Audifás-Salvador Matus-Meza, Julian M. Klein, Pedram Rikhtechi, Katie Brake, Daniel Carlson, Kiana Sherkat Sadi, Erika A. Cone, Tobin Shea, Jered C. Garrison. Exploration of the cysteine protease trapping approach to prolong tumor retention of antifolate targeted radionuclide therapeutics. Nuclear Medicine and Biology 2026; doi: 10.1016/j.nucmedbio.2026.109680
|
| 42 |
Manya D. Desai, Namrata B. Parmar, Neha R. Raghani, Rakesh B. Patel, Disha D. Shah, Mehul R. Chorawala, Bhupendra G. Prajapati. Ovarian Cancer. 2026; doi: 10.1016/B978-0-443-33536-5.00018-3
|
| 43 |
Shoichiro Yamanaka, Naoki Kawahara, Ryuji Kawaguchi, Keita Waki, Tomoka Maehana, Yosuke Fukui, Ryuta Miyake, Yuki Yamada, Hiroshi Kobayashi, Fuminori Kimura. The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy. Diagnostics 2022; 12(5) doi: 10.3390/diagnostics12051212
|
| 44 |
Seyedeh Sara Ghorbanhosseini, Mojtaba Amiri, Mustafa Ghanadian, Morteza Sadeghi, Mahmoud Aghaei. Synergistic effects of Lorestanol, an ursane-type triterpenoid from Euphorbia aleppica, in combination with cisplatin on apoptosis in cisplatin-resistant ovarian cancer cell lines. Toxicology and Applied Pharmacology 2025; 505 doi: 10.1016/j.taap.2025.117583
|
| 45 |
Alice Filipe, Sayeh Saravi, Denis Mustafov, Suzana Panfilov, Simran Banger, Seyedehnajmeh Mousavikivaj, Maria Braoudaki, Senthilkumar Kailasam, Yasser Riazalhosseini, Michelle A. Sahai, Fotios Drenos, Cristina Sisu, Emmanouil Karteris. Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-05013-0
|
| 46 |
Shreya A Sahu, Deepti Shrivastava. A Comprehensive Review of Screening Methods for Ovarian Masses: Towards Earlier Detection. Cureus 2023; doi: 10.7759/cureus.48534
|
| 47 |
Foteini Chouliara, Aikaterini Sidera, Ioannis Tsakiridis, Areti Kourti, Georgios Michos, Evangelos Papanikolaou, Themistoklis Dagklis, Apostolos Mamopoulos, Kali Makedou, Ioannis Kalogiannidis. The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study. Journal of Clinical Medicine 2026; 15(6) doi: 10.3390/jcm15062178
|
| 48 |
Millicent Gesare Morefu, Amsalu Degu. An assessment of the prevalence of drug therapy problems and its associated factors among ovarian cancer patients at Kenyatta National Hospital. Journal of Oncology Pharmacy Practice 2026; 32(6) doi: 10.1177/10781552251331479
|
| 49 |
S.M. Zahraa, A.M. Zainab.
Levels of sPD-L1 and sPD-1 in Women with Toxoplasma Gondii Infection and Ovarian Cancer in Thi-Qar
. Клиническая инфектология и паразитология 2026; 15(1) doi: 10.34883/PI.2026.15.1.039
|
| 50 |
Leila Allahqoli, Afrooz Mazidimoradi, Fatemeh Rezaei, Zahra Pasokh, Sevil Hakimi, Zohre Momenimovahed, Seyedeh Zahra Aghamohammadi, Azam Rahmani, Arezoo Fallahi, Atieh Karimzadeh, Hamid Salehiniya, Ibrahim Alkatout. Global Trend of Ovarian Cancer Among old age women: an Analysis by Socio-Demographic Index and Geographic Regions. Indian Journal of Gynecologic Oncology 2024; 22(4) doi: 10.1007/s40944-024-00915-9
|
| 51 |
O. N. Guskova, I. A. Alliluev, E. V. Verenikina, V. V. Polovodova, M. A. Rogozin, T. Yu. Myagkova, M. L. Adamyan, O. E. Zhenilo, N. M. Abdullaeva, M. R. Tsandekova, N. D. Ushakova, D. S. Kutilin. Changes in urine metabolite concentration as a minimally invasive marker of ovarian serous adenocarcinoma. Russian Journal of Biotherapy 2023; 22(3) doi: 10.17650/1726-9784-2023-22-3-43-50
|
| 52 |
Naoki Kawahara, Ryuji Kawaguchi, Tomoka Maehana, Shoichiro Yamanaka, Yuki Yamada, Hiroshi Kobayashi, Fuminori Kimura. The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma. Biomedicines 2022; 10(11) doi: 10.3390/biomedicines10112683
|
| 53 |
Mark Bates, Bashir M. Mohamed, Faye Lewis, Sharon O’Toole, John J. O’Leary. Biomarkers in high grade serous ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(6) doi: 10.1016/j.bbcan.2024.189224
|
| 54 |
Zheng Cao, ZiKun Song, Weijie Zhou, Xiaohui Liu, Yanling Liu, Peng R. Chen, Kun Qian. Mass spectrometry‐based mitochondrial proteomics for cancer biomarker discovery. VIEW 2026; 7(2) doi: 10.1002/VIW.20250171
|
| 55 |
James P. Beirne, Alan Gilmore, Caitríona E. McInerney, Aideen Roddy, W. Glenn McCluggage, Ian J.G. Harley, M. Abdullah Alvi, Kevin M. Prise, Darragh G. McArt, Paul B. Mullan. A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer. Computational and Structural Biotechnology Journal 2022; 20 doi: 10.1016/j.csbj.2022.06.016
|
| 56 |
Jin Wang, Xiaoyan Pan, Junyu Zhang, Qingqing Zhang, Yanchen Li, Weiwei Guo, Jie Zhang. Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters 2024; 35(8) doi: 10.1016/j.cclet.2023.109187
|
| 57 |
Naoki Kawahara, Hiroki Kuniyasu, Shiori Mori, Shingo Kishi, Sumire Sugimoto, Tomoka Maehana, Shoichiro Yamanaka, Ryuji Kawaguchi, Fuminori Kimura. Inhibition of glycolysis and stimulation of mitochondrial biogenesis lead to increased ROS levels and cell death in HNF-1ß positive clear cell carcinoma. Cell Death & Disease 2025; 16(1) doi: 10.1038/s41419-025-08243-2
|
| 58 |
Yanling Liu, Shouzhi Yang, Shunxiang Li, Yuning Wang, Xiaohui Liu, Wei Xu, Haiyang Su, Kun Qian. Noble Metal Nanoparticle Assisted Mass Spectrometry for Metabolite‐Based In Vitro Diagnostics. Small 2025; 21(4) doi: 10.1002/smll.202409714
|